Skip to main content

Table 3 Patient characteristics

From: The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group

Characteristics Low (n = 17) Intermediate (n = 70) High (n = 66) p-value*
Gender     0.17
   Male 13 (76%) 48 (69%) 37 (56%)  
   Female 4 (24%) 22 (31%) 29 (44%)  
Race     0.88
   White 15 (88%) 66 (94%) 63 (95%)  
   Hispanic 1 (6%) 1 (1%) 1 (2%)  
   Black 1 (6%) 2 (3%) 2 (3%)  
   Other 0 1 (1%) 0  
Neurologcal Function (Symptoms)     0.69
   None/Minor 7 (41%) 40 (57%) 37 (56%)  
   Moderate 8 (47%) 25 (36%) 25 (38%)  
   Major/Severe 2 (12%) 5 (7%) 3 (5%)  
   Missing 0 0 1 (1%)  
KPS     0.41
   ≤ 60 4 (24%) 7 (10%) 6 (9%)  
   70–80 8 (47%) 29 (41%) 30 (45%)  
   90–100 5 (29%) 34 (49%) 30 (45%)  
Prior Surgery     0.84
   Biopsy 0 5 (7%) 5 (8%)  
   Partial Resection 11 (65%) 42 (60%) 37 (56%)  
   Total Resection 6 (35%) 22 (31%) 23 (35%)  
   Unknown 0 1 (1%) 1 (1%)  
RPA     0.08
   III 3 (18%) 20 (28%) 6 (9%)  
   IV 7 (41%) 25 (36%) 31 (47%)  
   V 7 (41%) 25 (36%) 29 (44%)  
Study     
   7401 6 (35%) 22 (31%) 10 (15%)  
   7918 3 (18%) 4 (6%) 2 (3%)  
   8302 4 (23%) 16 (23%) 10 (15%)  
   8409 0 1 (1%) 0  
   9006 1 (6%) 13 (19%) 18 (27%)  
   9305 1 (6%) 1 (1%) 1 (1%)  
   9602 2 (12%) 3 (4%) 8 (12%)  
   9806 0 10 (14%) 17 (26%)  
  1. * Chi-square Tests